BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35422288)

  • 1. In vitro fermentation of human milk oligosaccharides by individual Bifidobacterium longum-dominant infant fecal inocula.
    Li H; Lane JA; Chen J; Lu Z; Wang H; Dhital S; Fu X; Huang Q; Liu F; Zhang B
    Carbohydr Polym; 2022 Jul; 287():119322. PubMed ID: 35422288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense.
    Bunesova V; Lacroix C; Schwab C
    BMC Microbiol; 2016 Oct; 16(1):248. PubMed ID: 27782805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct fermentation of human milk oligosaccharides 3-FL and LNT2 and GOS/inulin by infant gut microbiota and impact on adhesion of
    Kong C; Akkerman R; Klostermann CE; Beukema M; Oerlemans MMP; Schols HA; de Vos P
    Food Funct; 2021 Dec; 12(24):12513-12525. PubMed ID: 34811557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infant-gut associated Bifidobacterium dentium strains utilize the galactose moiety and release lacto-N-triose from the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose.
    Moya-Gonzálvez EM; Rubio-Del-Campo A; Rodríguez-Díaz J; Yebra MJ
    Sci Rep; 2021 Dec; 11(1):23328. PubMed ID: 34857830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota.
    Yu ZT; Chen C; Kling DE; Liu B; McCoy JM; Merighi M; Heidtman M; Newburg DS
    Glycobiology; 2013 Feb; 23(2):169-77. PubMed ID: 23028202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes.
    Yu ZT; Chen C; Newburg DS
    Glycobiology; 2013 Nov; 23(11):1281-92. PubMed ID: 24013960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of Bifidobacterium breve.
    Ruiz-Moyano S; Totten SM; Garrido DA; Smilowitz JT; German JB; Lebrilla CB; Mills DA
    Appl Environ Microbiol; 2013 Oct; 79(19):6040-9. PubMed ID: 23892749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An In Vitro Colonic Fermentation Study of the Effects of Human Milk Oligosaccharides on Gut Microbiota and Short-Chain Fatty Acid Production in Infants Aged 0-6 Months.
    Li M; Lu H; Xue Y; Ning Y; Yuan Q; Li H; He Y; Jia X; Wang S
    Foods; 2024 Mar; 13(6):. PubMed ID: 38540911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method for the Determination of 2'-Fucosyllactose (2'-FL), 3-Fucosyllactose (3-FL), 6'-Sialyllactose (6'-SL), 3'-Sialyllactose (3'-SL), Lacto-N-Tetraose (LNT), and Lacto-N-neoTetraose (LNnT) by High-Performance Anion-Exchange Chromatography With Pulsed Amperometric Detection (HPAEC-PAD): First Action 2022.04.
    Haselberger P; Tian F; Erney R; Liu S; Wang S; Lin Q; Ding Y
    J AOAC Int; 2023 Sep; 106(5):1237-1245. PubMed ID: 37341636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Milk Oligosaccharide Utilization in Intestinal Bifidobacteria Is Governed by Global Transcriptional Regulator NagR.
    Arzamasov AA; Nakajima A; Sakanaka M; Ojima MN; Katayama T; Rodionov DA; Osterman AL
    mSystems; 2022 Oct; 7(5):e0034322. PubMed ID: 36094076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining galacto-oligosaccharides and 2'-fucosyllactose alters their fermentation kinetics by infant fecal microbiota and influences AhR-receptor dependent cytokine responses in immature dendritic cells.
    Akkerman R; Logtenberg MJ; Beukema M; de Haan BJ; Faas MM; Zoetendal EG; Schols HA; de Vos P
    Food Funct; 2022 Jun; 13(12):6510-6521. PubMed ID: 35642586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Infant Fecal Fermentation Characteristics of Human Milk Oligosaccharides Were Controlled by Initial Microbiota Composition More than Chemical Structure.
    Xu S; Lane JA; Chen J; Zheng Y; Wang H; Fu X; Huang Q; Dhital S; Liu F; Zhang B
    Mol Nutr Food Res; 2022 Oct; 66(19):e2200098. PubMed ID: 35989465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria.
    Asakuma S; Hatakeyama E; Urashima T; Yoshida E; Katayama T; Yamamoto K; Kumagai H; Ashida H; Hirose J; Kitaoka M
    J Biol Chem; 2011 Oct; 286(40):34583-92. PubMed ID: 21832085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro.
    Natividad JM; Marsaux B; Rodenas CLG; Rytz A; Vandevijver G; Marzorati M; Van den Abbeele P; Calatayud M; Rochat F
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversification of a Fucosyllactose Transporter within the Genus
    Ojima MN; Asao Y; Nakajima A; Katoh T; Kitaoka M; Gotoh A; Hirose J; Urashima T; Fukiya S; Yokota A; Abou Hachem M; Sakanaka M; Katayama T
    Appl Environ Microbiol; 2022 Jan; 88(2):e0143721. PubMed ID: 34731055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inefficient Metabolism of the Human Milk Oligosaccharides Lacto-
    Özcan E; Sela DA
    Front Nutr; 2018; 5():46. PubMed ID: 29900174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Human Milk Oligosaccharides and
    Salli K; Hirvonen J; Anglenius H; Hibberd AA; Ahonen I; Saarinen MT; Maukonen J; Ouwehand AC
    Microorganisms; 2023 Jun; 11(6):. PubMed ID: 37375055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Seven Human Milk Oligosaccharides (HMOs) in Infant Formula and Adult Nutritionals: First Action 2022.07.
    Bénet T; Frei N; Spichtig V; Cuany D; Austin S
    J AOAC Int; 2024 Mar; 107(2):286-302. PubMed ID: 38218728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weighted analysis of 2'-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, 3'-sialyllactose, and 6'-sialyllactose concentrations in human milk.
    Conze DB; Kruger CL; Symonds JM; Lodder R; Schönknecht YB; Ho M; Derya SM; Parkot J; Parschat K
    Food Chem Toxicol; 2022 May; 163():112877. PubMed ID: 35304182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro fermentation characteristics of select nondigestible oligosaccharides by infant fecal inocula.
    Vester Boler BM; Rossoni Serao MC; Faber TA; Bauer LL; Chow J; Murphy MR; Fahey GC
    J Agric Food Chem; 2013 Mar; 61(9):2109-19. PubMed ID: 23379900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.